🇺🇸 JDP-205 Injection in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised JDP-205 Injection on 4 October 2019

Marketing authorisation

FDA — authorised 4 October 2019

Application: NDA211415
Marketing authorisation holder: ESTEVE
Local brand name: QUZYTTIR
Indication: SOLUTION — INTRAVENOUS
Status: approved

Read official source →

Other Oncology approved in United States

Frequently asked questions

Is JDP-205 Injection approved in United States?

Yes. FDA authorised it on 4 October 2019.

Who is the marketing authorisation holder for JDP-205 Injection in United States?

ESTEVE holds the US marketing authorisation.